Promises of Nanotherapeutics in Obesity
- PMID: 31126754
- PMCID: PMC6716370
- DOI: 10.1016/j.tem.2019.04.004
Promises of Nanotherapeutics in Obesity
Abstract
The application of nanotechnology to medicine promises a wide range of new tools and possibilities, from earlier diagnostics and improved imaging, to better, more efficient, and more targeted therapies. This emerging field could help address obesity, with advances in drug delivery, nutraceuticals, and genetic and epigenetic therapeutics. Its application to obesity is still largely in the development phase. Here, we review the novel angle of nanotech applied to human consumable products and their specific applications to addressing obesity through nutraceuticals, with respect to benefits and limitations of current nanotechnology methods. Further, we review potential future applications to deliver genetic and epigenetic miRNA therapeutics. Finally, we discuss future directions, including theranostics, combinatory therapy, and personalized medicine.
Keywords: diabetes; epigenetics; gene therapy; miRNA; nanotechnology; obesity.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Figures


References
-
- Benjamin EJ et al. Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. (2018) Circulation 137, e67–e492 - PubMed
-
- Cawley J and Meyerhoefer C The medical care costs of obesity: an instrumental variables approach. (2012) J Health Econ 31, 219–230 - PubMed
-
- Lehnert T et al. Economic costs of overweight and obesity. (2013) Best Pract Res Clin Endocrinol Metab 27, 105–115 - PubMed
-
- United Nations Department of Economic and Social Affairs. Global Sustainable Development Report 2016, https://sustainabledevelopment.un.org/index.php?page=view&type=400&nr=23... (2016).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical